Promoter of the human FATP5 gene and uses

Details for Australian Patent Application No. 2004268754 (hide)

Owner Merck Patent GmbH

Inventors Martin, Genevieve; Ruggiero, Daniel; Asfari, Maryam; Durbin, Philippe; Augert, Guy; Dupont, Herve

Agent Davies Collison Cave

Pub. Number AU-B-2004268754

PCT Pub. Number WO2005/021590

Priority 0310224 27.08.03 FR

Filing date 4 August 2004

Wipo publication date 10 March 2005

Acceptance publication date 12 May 2011

International Classifications

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

Event Publications

13 April 2006 PCT application entered the National Phase

  PCT publication WO2005/021590 Priority application(s): WO2005/021590

12 May 2011 Application Accepted

  Published as AU-B-2004268754

8 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004268762-Pentafluorosulfanyl phenyl-substituted benzoylguanidines, method for their production, their use as medicaments or diagnostic agents and medicament containing said compounds

2004268732-Method for the production of porous carbon-based molded bodies, and use thereof as cell culture carrier systems and culture systems